Medicine Matters podcasts

Health psychologist Michael Vallis, associate professor of family medicine at Dalhousie University in Halifax, Canada, discusses the psychosocial impact of the pandemic on people with diabetes, and how healthcare professionals can identify and support those who are struggling. Find more on Medicine Matters diabetes

In recognition of World Diabetes Day 2020 and the WHO “International Year of the Nurse and the Midwife” Sharon Tovey joins Editorial Board member Lori Berard to compare and contrast how nurses are making the difference to people with diabetes in the UK and North America, respectively. Find more on Medicine Matters diabetes

Sanjay Kalra, John Wilding and Lori Berard from the Medicine Matters diabetes Editorial Board reflect on their research highlights from this year’s virtual 56th EASD Annual Meeting. Find more on Medicine Matters diabetes

In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. We welcome back Professor Bill Polonsky, from the University of California at San Diego, USA. This time he is addressing disengagement with diabetes – the scale of the problem, why it is so critical yet good data remain so elusive, and what healthcare providers can do to encourage people with diabetes to engage with their disease management. Find more on Medicine Matters diabetes

In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. For this episode, we are joined by Dr Kirsty Winkley, diabetes nurse and health psychologist from King’s College London, UK, to discuss why people with diabetes can find it so challenging to take medications optimally and consistently, and what healthcare providers can do to help. Find more on Medicine Matters diabetes

In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. This episode features Professor Thomas Kubiak, from Johannes Gutenberg University, talking about the psychological considerations necessary for working with people using technology to manage their diabetes. Find more on Medicine Matters diabetes

In this series of podcasts we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes Study Group by taking a look at some of the most important and emerging topics within this field. In this episode, Dr Christel Hendrieckx, from the Australian Centre for Behavioural Research in Diabetes, at Deakin University in Melbourne, discusses the psychological impact of hypoglycemia in people with diabetes. Find more on Medicine Matters diabetes

In this series of podcasts, we are marking the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes study group by taking a look at some of the most important and emerging topics within this field. This episode features Professor William Polonsky, from the University of California at San Diego, discussing how diabetes distress affects the wellbeing and glucose management of people with diabetes, and what healthcare professionals can do to help. Find more on Medicine Matters diabetes

This year is the 25th anniversary of the EASD’s Psychosocial Aspects of Diabetes (PSAD) study group. Marking the occasion, the 'Why psychosocial care matters' podcast series will explore important and emerging topics with experts in psychosocial aspects of diabetes. To launch the series, we talk to Professor Frank Snoek, founder and first Chairperson of the study group, about its history and achievements, and the changing profile of psychosocial research in diabetes care. Find more on Medicine Matters diabetes

The DiRECT trial ran counter to received wisdom by advocating a very-low-calorie, total-meal-replacement diet as a means not just of weight loss but also of weight maintenance for people with type 2 diabetes. Trial dietitian Alison Barnes (Newcastle University, UK) speaks of her initial skepticism, and describes how the diet worked as a pragmatic way for people with type 2 diabetes to achieve weight loss and maintain it long term. Find more on Medicine Matters diabetes

Owing to the COVID-19 pandemic, the 80th ADA Scientific Sessions was an entirely online event. In this podcast, editorial board members Lori Berard, John Wilding, and Sanjay Kalra reflect on this novel format and discuss their scientific highlights. Find more on Medicine Matters diabetes

Following the wealth of artificial pancreas research presented at this year’s ADA Scientific Sessions, Rayhan Lal (Stanford University, California, USA) reflects on the current status of the field, and suggests where researchers and manufacturers should now be placing their focus for the greatest benefit of people with diabetes. Find more on Medicine Matters diabetes

Neil Skolnik, Professor of Family and Community Medicine at Sidney Kimmel Medical College in Philadelphia, Pennysylvania, USA, gives his view and outlines key considerations for the use of this new medication as part of a shared decision-making process with people who have type 2 diabetes. For more of the latest news and insights on diabetes medications, visit: https://bit.ly/MMd_medications

The first author on the American Diabetes Association's 2019 consensus on nutrition therapy for adults with diabetes or prediabetes talks through the update and what it means for educators, practitioners and patients. The full consensus document is available from Diabetes Care. Find more on Medicine Matters diabetes

Medical sociologist Ashby Walker, from the University of Florida in Gainesville, talks about a mentoring scheme pairing college students and teenagers who have type 1 diabetes - to the benefit of both. Find more on Medicine Matters diabetes

Listen to our clinical advisors discussing their EASD 2019 highlights, including new treatment options for children and older adults with type 2 diabetes, the complexities surrounding hypoglycemia prevention, and the implications of the VERIFY trial. Find more on Medicine Matter diabetes More from EASD 2019

How will the findings of the REWIND trial and the DECLARE-TIMI 58 renal outcomes analysis affect treatment decisions for high-risk diabetes patients without overt cardiovascular disease? medwireNews asks Kamlesh Khunti. Find more on Medicine Matters diabetes

Andrew Frankel, Consultant Physician and Nephrologist at Imperial College Healthcare NHS Trust, tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 17, 2019.

Editorial Board member Lori Berard discusses how to meet and overcome the challenges that follow the initial insulin prescription in patients with type 2 diabetes. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on August 1, 2018.

Board members John Wilding and Pamela Dyson talk about the fresh approach taken to the latest update of the Diabetes UK nutrition guidelines. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on March 19, 2018.

Editorial board member John Wilding discusses the lessons for healthcare professionals from the SGLT2 inhibitor cardiovascular outcome trials about the benefits and drawbacks of the medication class. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on September 8, 2017.

Listen to CANVAS investigators Carol Wysham and Lori Berard discussing the efficacy and safety findings of the trials. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on August 8, 2017.

Kevin Fernando, GP Partner at the North Berwick Health Centre near Edinburgh, UK, talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 17, 2019.

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 15, 2019.

Editorial Board member Lori Berard talks through the stages and challenges associated with preparing type 2 diabetes patients for insulin therapy. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on June 6, 2018.